Stock market today: S&P 500, Nasdaq futures hold steady amid more inflation cooldown

Published On Sep 12, 2024, 8:48 AM

On Thursday, US stocks saw a boost as fresh inflation and labor data raised expectations for a modest interest-rate cut. The S&P 500 and Nasdaq Composite both recorded gains for the fourth consecutive day, with tech companies leading the way. The Producer Price Index indicated cooling inflation, reinforcing expectations that the Federal Reserve will opt for a 25 basis point rate cut next week. However, Moderna's shares plummeted after the company reduced its revenue outlook for 2025. Additionally, gold prices soared to an all-time high as investors await the Fed's decision.

Read full article

Stock Forecasts

NVDAView NVDA chart on TradingView

Positive

The distinct upward trend in technology stocks, particularly Nvidia and Meta, suggests a positive outlook for the tech sector, especially with renewed investor confidence driven by a potential rate cut from the Fed. Additionally, the overall improvement in market sentiment about inflation and economic conditions supports this bullish view.

MRNAView MRNA chart on TradingView

Negative

Moderna's significant drop in share price after revising its revenue forecast down indicates negative sentiment around the company. This could cause further declines in the stock price as investors react to the news and uncertainty regarding the company's future performance.

Related News

Nancy Tengler encourages investors to have a ‘longer-term perspective’ on Magnificent 7 stocks | Fox Business Video

Laffer Tengler CEO and CIO Nancy Tengler discusses investment opportunities and more on ‘Making Money.'

AAPL
MSFT
NVDA

Nvidia stock aims for new record high as AI boom shows no sign of slowing

Oct 9, 2024, 12:23 PM

Nvidia stock is aiming to notch a new all-time high, as the AI boom shows no sign of slowdown.

NVDA

Nobel Prize in Chemistry Is Awarded to 3 Scientists for Work With Proteins

Oct 9, 2024, 5:49 AM

Demis Hassabis and John M. Jumper of Google DeepMind predicted protein shapes with A.I. while David Baker designed “a new protein that was unlike any other,” the committee said.

NVDA
EDIT